Impact of duloxetine on quality of life for women with symptoms of urinary incontinence

International Urogynecology Journal

Volumn 16, Issue 5, 2005, Pages 337-344

  Kinchen, Kraig S ^a   Obenchain, Robert ^a   Swindle, Ralph ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Duloxetine; Stress urinary incontinence

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; DULOXETINE; ESTROGEN; PHENYLPROPANOLAMINE; PLACEBO; PSEUDOEPHEDRINE;

ADULT; AGED; ANOREXIA; ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HEADACHE; HUMAN; INSOMNIA; LETHARGY; LIBIDO DISORDER; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MUSCLE TRAINING; MYCOSIS; NAUSEA; NIGHTMARE; PELVIS FLOOR; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SELF REPORT; SIDE EFFECT; SMOKING CESSATION; SOMNOLENCE; STATISTICAL SIGNIFICANCE; STRESS INCONTINENCE; SWEATING; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREMOR; URINE INCONTINENCE; VOMITING; WEIGHT REDUCTION; XEROSTOMIA;

EID: 20444479203     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00192-004-1270-5     Document Type: Article

References (21)

1. Diokno AC, Burgio K, Fultz NH, Kinchen KS, Obenchain R, Bump RC (2004) Medical and self-care practices reported by women with urinary incontinence. Am J Manag Care 10:69-78
2. Hampel C, Wienhold D, Benken N, Eggersmann C, Thuroff JW (1997) Definition of overactive bladder and epidemiology of urinary incontinence. Urology 50:4-14 10.1016/S0090-4295(97)00578-5
3. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et al (2002) The standardization of terminology of lower urinary tract function: Report from the Standardization Subcommittee of the International Continence Society. Neurourol Urodyn 21:167-178 10.1002/ nau.10052
4. Fultz NH, Burgio K, Diokno AC, Kinchen KS, Obenchain R, Bump RC (2003) Burden of stress urinary incontinence for community-dwelling women. Am J Obstet Gynecol 189:1275-1282
5. Lightner DJ, Itano NM (1999) Treatment options for women with stress urinary incontinence. Mayo Clin Proc 74:1149-1156
6. Espey MJ, Downie JW, Fine A (1992) Effect of 5-HT receptor and adrenoceptor antagonists on micturition in conscious cats. Eur J Pharmacol 221:167-170 10.1016/0014-2999(92)90788-6
7. Danuser H, Thor KB (1996) Spinal 5-HT2 receptor-mediated facilitation of pudendal nerve reflexes in the anaesthetized cat. Br J Pharmacol 118:150-154
8. Gajewski J, Downie JW, Awad SA (1984) Experimental evidence for a central nervous system site of action in the effect of alpha-adrenergic blockers on the external urinary sphincter. J Urol 132:403-409 1:CAS:528:DyaL2cXlt1ekurk%3D
9. Thor KB, Katofiasc MA (1995) Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat. J Pharmacol Exp Ther 274:1014-1024 1:CAS:528:DyaK2MXnsFSjur4%3D
10. Norton PA, Zinner RN, Yalcin I, Bump RC (2002) Duloxetine versus placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol 187:40-48 10.1067/mob.2002.124840
11. Dmochowski RR, Miklos JR, Norton PA, Zinner NR, Yalcin I, Bump RC (2003) Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. J Urol 170:1259-1263 10.1097/ 01.ju.0000080708.87092.cc
12. van Kerrebroeck P, Abrams P, Lange R, Slack M, Wyndaele J-J, Yalcin I, Bump RC (2004) Duloxetine UI Study Group. Duloxetine vs. placebo in the treatment of European and Canadian women with stress urinary incontinence. Br J Obstet Gynaecol 111:249-257
13. Millard RJ, Moore K, Rencken R, Yalcin I, Bump RC (2004) For the Duloxetine UI Study Group. Duloxetine versus placebo in the treatment of stress urinary incontinence: A four continent randomized clinical trial. Br J Urol Int 93:311-318
14. Patrick DL, Martin ML, Bushnell DM, Yalcin I, Wagner TH, Buesching DP (1999) Quality of life of women with urinary incontinence: Further development of the incontinence quality of life instrument (I-QOL). Urology 53:71-76 10.1016/S0090-4295(98)00454-3
15. Yalcin I, Bump RC (2003) Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol 189:98-101
16. J Winslade DR Hutchinson 1992 Dictionary of clinical research Brookwood Medical Publications Brookwood
17. Bump R, Hooper C, Koke S, Yalcin I (2003) Worldwide efficacy of duloxetine after 12 weeks and 1 year in women with stress urinary incontinence (SUI): A 4-study meta-analysis International Continence Society meeting, Florence
18. Cardozo L, Drutz HP, Baygani SK, Bump RC (2004) Pharmacological treatment of women awaiting surgery for stress urinary incontinence. Obstet Gynecol 104:511-519
19. Tunis SR, Stryer DB, Clancy CM (2003) Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 290:1624-1632
20. Herbison P, Hay-Smith J, Ellis G, Moore K (2003) Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: A systematic review. BMJ 326:841-844 10.1136/ bmj.326.7394.841
21. Yalcin I, Bump RC, Versi E, Schaefer W, Benson JT (2004) Validation of a clinical algorithm indicative of urodynamic stress incontinence for use in large-scale clinical trials. J Urol 171:2321-2325